Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 3 boards, counting each seat separately. Longest: Candel Therapeutics Inc., 3 years.
Candel Therapeutics Inc.
Director
Emergent BioSolutions Inc.
Director · President and CEO
Milestone Pharmaceuticals Inc.
Director
Chief executive roles
Emergent BioSolutions Inc.
· President and CEO
Since February 2024
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Milestone Pharmaceuticals Inc. June 10, 202685.7%
-
Emergent BioSolutions Inc. April 29, 202694.2%
-
Milestone Pharmaceuticals Inc. June 10, 202575.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 29, 2026 | Emergent BioSolutions Inc. | Grant or award | +187,708 | — | — |
| Mar 5, 2026 | Emergent BioSolutions Inc. | Shares withheld for tax | −37,055 | $8.44 | $312,744 |
| Jul 11, 2025 | Milestone Pharmaceuticals Inc. | Grant or award | +100,000 | — | — |
| Jun 25, 2025 | Candel Therapeutics Inc. | Grant or award | +64,239 | $4.67 | $299,996 |
| May 13, 2025 | Emergent BioSolutions Inc. | Open-market purchase | +60,000 | $5.83 | $349,800 |
| Mar 6, 2025 | Emergent BioSolutions Inc. | Grant or award | +282,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.